Human adenine phosphoribosyltransferase: Characterization from subjects with a deficiency of enzyme activity by Gault, M. Henry et al.
Biochemical Genetics, Vol. 21, Nos. 11/12, 1983 
Human Adenine Phosphoribosyltransferase: 
Characterization from Subjects with a 
Deficiency of Enzyme Activity 
Timothy E. O' Toole, 1 James M. Wilson, 1 M. Henry Gault, 2 and William N. 
Kelley ~ 
Received 2 Mar. 1983--Final 18 May 1983 
Adenine phosphoribosyltransferase (APRT) was characterized with respect 
to specific activity and immunoreactive protein (CRM) levels in hemolysate 
from 18 members of an APRT-deficient kindred. In addition, lymphoblas- 
toid cell lines were established from six of these subjects and APRT from 
these cells was characterized in a similar fashion. Levels of  specific activity 
and CRM in patients homozygous for the deficiency were less than 1% of 
normal. Heterozygous subjects had higher levels of  activity and CRM in 
lymphoblasts than in erythrocytes and, in all cases, the APRT present was 
normal in terms of isoelectric point, subunit molecular weight, and heat 
stability. The higher levels of activity and CRM found in lymphoblasts may 
be due either to expression of a mutant gene product stabilized in a 
normal:mutant dimer or to autologous regulation. 
KEY WORDS: adenine phosphoribosyltransferase (APRT) deficiency; protein blotting; lympho- 
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I N T R O D U C T I O N  
Aden ine  phosphor ibosyl t ransferase  ( A P R T ;  EC 2.4.2.7) is a pur ine  salvage 
enzyme ca ta lyz ing  the format ion  of  A M P  from adenine  and PP-r ibose-P.  A 
deficiency of  the enzyme in humans  is inher i ted in an autosomal  recessive 
Departments of Internal Medicine and Biological Chemistry, Human Purine Research Center, 
University of Michigan Medical School, Ann Arbor, Michigan 48109. 
2 Health Sciences Center, Department of Medicine, Memorial University of New Foundland, St. 
Johns, New Foundland. 
1121 
0006-2928/83/1200-1121503.00/0 © 1983 Plenum Publishing Corporation 
1122 O'Toole, Wilson, Gault, and Kelley 
manner and is manifested in some homozygotes by the formation of kidney 
stones composed of 2,8-dioxyadenine (Kelley et al., 1968; Debray et al., 1976; 
VanAcker et al., 1977). Patients heterozygous for APRT deficiency have no 
characteristic biochemical or clinical abnormalities (Kelley et al., 1968; Fox 
et al., 1973). 
Although the lack of enzyme activity which leads to the formation of 
2,8-dioxyadenine stones has been well documented (Debray et al., 1976; 
VanAcker et al., 1977; Barratt et al., 1979), little is known about the genetic 
mechanisms which are responsible for the enzyme deficiency state. Inborn 
errors of metabolism frequently result from structural gene mutations which 
render the mutant protein inactive or less active catalytically. Alternatively, 
such enzymatic defects may be due to a mutation which affects the steady 
state level of an enzyme with normal catalytic function. Such mutations alter 
the rates of synthesis or degradation of the protein. 
In a previous study we have characterized APRT in hemolysate from a 
number of families with a deficiency of the enzyme (Wilson et al., 1981a). 
Our results consistently showed less than 1% of normal specific activity and 
immunoreactive protein (CRM) in homozygotes, whereas heterozygotes 
exhibited approximately 25% of the normal specific activity and CRM in 
hemolysate rather than the 50% of normal levels which would have been 
expected. This unusual finding in heterozygotes ha's been explained by the 
proposal that an APRT dimer containing the product of a mutant allele is 
unusually labile (Kelley et al., 1968; Wilson et al., 1981a). In effect, it is 
suggested that there is equal expression of both alleles, with random associa- 
tion of their products, and that only dimers with two normal subunits, or 25% 
of the population of APRT molecules, are stable and thus detectable. Because 
erythrocytes are enucleated and do not synthesize new protein, they may not 
be the ideal tissue to study this phenomenon. Cultured lymphoblasts, which do 
synthesize new protein, may be a better tissue for exploring the specific 
mechanisms responsible for APRT deficiency. In our present investigation we 
have characterized APRT in hemolysate from a new kindred and have 
compared our results with those obtained in lymphoblast cell lines derived 
from members of this kindred. This kindred also represents the first North 
American APRT-deficient family reported (Gault et al., 1981). 
MATERIALS AND METHODS 
Cell Preparation and Extracts 
Fresh blood (20 ml) was obtained from the 18 patients by drawing the samples 
into heparinized tubes. Half of the blood was centrifuged for 30 rain at 600g. 
The plasma and buffy coat were removed by aspiration, while the red cells 
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were washed twice with an equal volume of 0.9% NaCI, lysed by freeze- 
thawing, and stored at -20°C until ready for use. In addition, lymphoblast 
cell lines were established from six of the subjects, including five heterozy- 
gotes and one homozygote essentially as described previously (Wilson et  al., 
1982). Lymphoblast extracts were prepared by harvesting 20-40 × 10 6 cells 
growing in log phase, freeze-thawing the cells six times in a small volume (0.8 
to 1.0 ml) of 10 mM Tris-HC1, pH 7.4, containing 154 mM NaC1, and 
centrifuging for 30 min in a Beckman airfuge. The final protein concentration 
of these extracts ranged from 1.0 to 3.0 mg/ml. 
APRT Assays 
APRT activity and immunoreactive (CRM) assays were conducted on 
dilutions of hemolysate or lymphoblast extract. Enzyme activity was assayed 
by a previously described radiochemieal method (Holden et al., 1979). The 
specific activity is expressed as milliunits of enzyme activity per milligram of 
protein. One unit of enzyme activity is defined as the amount of enzyme 
necessary to catalyze the formation of 1 #tool of AMP/rain. APRT immuno- 
reactive protein was measured using a previously described radioimmunoas- 
say (Wilson et al., 198 la). Levels of immunoreactive protein were expressed 
as nanograms of CRM per milligram of protein. 
Hypoxanthine-guanine phosphoribosyltransferase activity was assayed 
as described previously (Holden and Kelley, 1978) and expressed as milliunits 
of enzyme activity per milligram of protein. One unit of enzyme activity is 
defined as the amount of enzyme necessary to catalyze the formation of 1 
#mol of IMP/rain. 
Protein was assayed according to the method of Lowry (Lowry et al., 
1951) using bovine serum albumin as the standard. 
Isoelectric Focusing and Protein Blotting 
Isoelectric focusing of samples was done as previously described (Wilson et 
al., 1981 a). To aid our focusing and detection techniques, APRT was partially 
purified from hemolysate before these experiments (Wilson et  al., 1981a). 
Lymphoblast extracts were used without further purification. The protein 
blotting and immunochemical detection of APRT were done as previously 
described (Wilson et  al., 1981a). 
SDS Gel Electrophoresis and Protein Blotting 
Partially purified hemolysate or lymphoblast extract was subjected to SDS 
gel electrophoresis essentially as described previously (Wilson et  al., 1982). 
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Proteins were transferred from polyacrylamide gels to nitrocellulose paper by 
electrophoresis in a BioRad Transblot for 3 hr at 70 V using buffer A [20 mM 
Tris-base, pH 8.0, including 150 mM glycine and 20% methanol (v/v)]. 
APRT was immunochemically detected as was done for isoelectric focusing 
blots. 
Heat Stability 
Lymphoblast extract (200-500/~1) was dialyzed for 24 hr at 2°C against 
buffer B (10 mM Tris-HCl, pH 7.4, including 0.9% NaC1). Dialyzed extracts 
derived from both normal and heterozygous subjects were diluted to similar 
protein concentrations (approximately 1.5 mg/ml) and heated in a water bath 
at 46-48°C. At time intervals an aliquot was removed and assayed for APRT 
activity. Activity remaining was expressed as a percentage of the activity in 
the unheated extract. 
RESULTS 
Blood from 18 subjects of the New Foundland family was obtained and 
erythrocyte APRT characterized. A pedigree of the family is illustrated in 
Fig. 1. These 18 subjects include a previously described homozygote for 
APRT deficiency, 1I-3 (Gault et al., 1981), and a homozygous deficient 
sibling, II-11, who is as yet asymptomatic. 
Erythrocyte Specific Activity and Immunoreactivity 
The specific activities of APRT in hemolysates from each of the 18 subjects 
are listed in Table I. Hemolysates from each of the two homozygotes have less 
than 1% of normal specific activity. Hemolysates from the 10 heterozygotes in 
this family exhibit a specific activity of APRT ranging from 20 to 39% of 
III ~ )  HETEROZYGOTES 
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Fig. 1. Pedigree of the New Foundland family, nt, not tested. 
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normal, with an average of 28%. The six apparently normal subjects in the 
family have an average specific activity of 0.38 mU/mg in hemolysate, well 
within the published range (Wilson et al., 1981 a). 
Levels of immunoreactive APRT protein in hemolysate are also listed in 
Table I. Each homozygote had approximately 0.6 to 1% of the normal level. 
Heterozygotes had CRM levels ranging from 17 to 54% of normal, with an 
average of 34%. The six normal patients had CRM levels in hemolysate well 
within the published range (Wilson et al., 198 la). 
Within the heterozygotes there may be two separate ranges of activity 
and CRM. The parents and siblings of the two homozygotes have a specific 
activity ranging from 20 to 28% of normal, while four other heterozygotes, 
children of one homozygote, have an activity range from 35 to 39% of normal. 
In a similar fashion, the CRM level of heterozygous individuals in the first two 
generations ranges from 17 to 45% of normal, while CRM levels in the third 
generation of heterozygotes have a range of 38-54% of normal. 
The absolute specific activity of APRT in hemolysate, the ratio of 
specific activity to CRM, is listed in Table 1. In all cases including the two 
Table II. Characterization of Erythrocyte HPRT in the NF  Family 
Sp act 
Subject (mU/mg)  
Control 
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homozygotes studied, absolute specific activity was normal, except for subject 
1I-8. In subject I1-8 the absolute specific activity of APRT is about half of 
normal. 
The specific activity of the purine salvage enzyme, HPRT, in hemolysate 
from each subject was indistinguishable from normal (Table 11). 
Lymphoblast Specific Activity and lmmunoreactivity 
The specific activities of APRT in extracts from the six cultured lymphoblast 
cell lines are listed in Table III. A normal range of lymphoblast APRT specific 
activity (10.0 +_ 1.2 mU/mg) was established in extracts from four cell 
lines,MGL8, WlL2, GM 130, and GM 558. The five heterozygotes studied 
had specific activities ranging from 39 to 55% of normal, with an average of 
46%, while the ccll linc derived from one homozygote had 4% of normal 
specific activity. 
Levels of CRM in lymphoblasts extracts are also listed in Table III. 
Using the same four cell lines, a normal range was established (405 _+ 65 ng 
CRM/mg protein). The five heterozygotes tested had CRM levels ranging 
from 28 to 55% of normal, with an average of 41%, while the homozygotc had 
1% of normal CRM. 
The trend of separate ranges of activity and CRM between hetcrozygotcs 
of thc first two and the third generations, as obscrved in crythrocytes, is less 
apparent when the specific activity and CRM are determined from lympho- 
blast extracts. 
The absolute specific activity of APRT in lymphoblasts is listed in Table 
III. Cells derived from each subject studied exhibited a normal absolute 
specific activity except for thc cells from subject III-4, whose value may be 
slightly elevated. The absolute specific activity of APRT in both hcmolysate 
and lymphoblast extracts is the same as that for the highly purified enzyme 
(22 mU/~g). 
Isoelectric Points 
Isoelectric focusing gels and protein blots were performed as described in 
Materials and Methods. An autoradiograph of an erythrocyte isoelectric 
focusing blot is shown in Fig. 2. Six heterozygotes (lanes A and B; F-I) showed 
identical migration with normal (lane D). The two homozygotes (lanes C and 
E) do not have enough APRT CRM to be detected. A similar autoradiograph 
of an isoelectric focusing blot of APRT from cultured lymphoblasts is shown 
in Fig. 3. The five heterozygotes (lanes A, B, and E-G) have the same 
migration as normal (lane D) and only a single band is observed. The one 
homozygote studied (lane C) again had too little CRM to be detected. 
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Fig. 2. Autoradiograph of erythrocyte isoelectric focusing blot of APRT. Isoelectric focusing 
protein transfer and immunochemical detection of APRT were done as described in MateriaJs 
and Methods. Approximately equal amounts of protein were used in all lanes. Lane A, I- 1; lane B, 
I1-2; lane C, I1-3; lane D, 11-6; lane E, II-11; lane F, II-10; lane G, 11-7; lane H, 11-8; lane I, 1-2. 
The isoelectric point of all enzymes is normal (lane D) and no reproducible second band is seen. 
Apparent Subunit Molecular Weight 
The electrophoretic migration of  A P R T  under denaturing conditions was 
studied as described in Materials and Methods. An  autoradiograph of  a 
lymphoblast  SDS P A G E  blot is shown in Fig. 4. Four heterozygotes (lanes 
A - D )  show identical migrat ion to normal (lane F). The one homozygote (lane 
E) has too little C R M  to be detected. A similar SDS P A G E  blot of  A P R T  
partially purified from hemolysate of  heterozygous and normal subjects has 
exhibited no abnormal  migration (data not shown). 
Heat Stability 
The five heterozygous and one normal (WIL2)  lymphoblast  cell line were 
studied with regards to heat stability as described in Materials and Methods. 
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Fig. 3. Autoradiograph of lymphoblast isoelectric focusing 
blot of APRT. Isoelectric focusing protein transfer and immu- 
nochemical detection of APRT were done as described in 
Materials and Methods. Approximately equal amounts of 
protein were used in all lanes. Lane A, II-10; lane B, 111-4; lane 
C, II-11; lane D, MGL8; lane E, I-2; lane F, III-2; lane G, I-1. 
The isoelectric point of all enzymes is normal (lane D) and no 
second band is seen. 
The rate of  loss of A P R T  activity appears identical in lymphoblast  extracts 
from both normal and heterozygous individuals (Fig. 5). 
D I S C U S S I O N  
Previous studies of  A P R T  deficiency using erythrocytes f rom affected individ- 
uals revealed the unique occurrence of unusually low levels of A P R T  in 
heterozygotes (Kelley et al., 1968; Wilson et al., 198 la).  Because erythrocytes 
are enucleated and do not have the genetic machinery of a dividing cell, 
however, this cell type was not the most suitable for studying the properties of 
A P R T  gene expression. For this reason we have chosen to study the properties 
of  A P R T  in cultured lymphoblasts derived from enzyme deficient subjects in 
A B C  D E F 
Fig. 4. Autoradiograph of SDS PAGE blot 
of APRT. SDS-polyacrylamide gel electro- 
phoresis, protein transfer, and immunochem- 
ical detection of A P R T  were done as 
described in Materials and Methods. Ap- 
proximately equal amounts of protein were 
used in all lanes. Lane A, I-1; lane B, 111-2; 
lane C, II-10; lane D, III-4; lane E, II-11; 
lane F, WIL2. The migration of all enzymes 
is identical to normal (lane F) and no second 
band is seen. 
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Fig. 5. Representative semilog plot of the heat stability 
of lymphoblast APRT. Heat stability experiments were 
conducted as described in Materials and Methods and 
the rate of loss of APRT activity was determined via 
linear regression analysis. Filled circles and solid line, 
WlL2. Open circles and dashed line, II-10.The rate of 
activity loss in the four other heterozygotes studied is 
indistinguishable. 
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one family and to compare the findings with results obtained in hemolysate 
from the same individuals. We have, therefore, examined APRT in erythro- 
cytes from 18 subjects spanning three generations in a single kindred and in 
cultured lymphoblasts from 6 of these 18 subjects. 
In the present study, the specific activity of APRT in erythrocytes from 
heterozygotes averaged 28% of normal, while CRM levels were 34% of 
normal. The levels of activity and CRM in homozygotes were less than 1% of 
normal. These findings confirm our earlier study of other families (Wilson et 
al., 1981a), again noting that heterozygotes have levels of enzyme activity 
substantially lower than the expected 50% of normal. Using cultured lympho- 
blasts, however, levels of APRT specific activity and CRM are close to the 
expected 50% level. 
The higher levels of APRT activity found in cultured lymphoblasts 
derived from heterozygotes is consistent with the model proposed earlier to 
account for the low level of erythrocyte APRT activity in heterozygotes. 
Because lymphoblasts are actively synthesizing new protein, "hybrid" dimers, 
composed of one normal and one mutant subunit, may exist even though they 
are abnormally labile. Thus, in cultured lymphoblasts derived from heterozy- 
gotes, the activity and CRM levels represent a combination of that contrib- 
uted by normal:normal dimers and that contributed by normal:mutant dimers 
which have yet to lose activity. According to this hypothesis, such mutant gene 
expression and the existence of a putative "hybrid" dimer are not seen in 
erythrocytes because this labile protein species is degraded too rapidly. 
Molecular variants of peptidase A (Sinka et al., 1970; Lewis, 1973), isocitrate 
dehydrogenase (Turner et al., 1973), and peptidase C (Povey et al., 1972) are 
other examples where mutant gene expression is observed in other tissues but 
not in erythrocytes, presumably for the reason noted above. Alternately, the 
higher levels of activity and CRM found in cultured lymphoblasts may be due 
to a compensatory mechanism in the cell which increases the expression of the 
normal allele, while either the mutant allele is not expressed or its product is 
labile and undetectable by these assays. In this case, presumably, such 
metabolic regulation or compensation of APRT levels is not possible with 
erythrocytes, and consequently only levels of about 25% of normal are 
observed. 
In our efforts to distinguish between these possibilities, we have 
attempted to find evidence for the existence of a mutant gene product by 
examining the isoelectric point, electrophoretic migration under denaturing 
conditions, and heat stability of APRT in erythrocytes and cultured lympho- 
blasts from subjects heterozygous for APRT deficiency in a single family. In 
our previous study (Wilson et al., 198 la), an apparent mutant APRT subunit 
which had a more acidic isoelectric point was detected in hemolysate from one 
subject. In this study, however, the isoelectric point and electrophoretic 
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migration of erythrocyte APRT from all heterozygotes were indistinguishable 
from normal. While expression of the mutant allele should have been more 
readily detectable in cultured lymphoblasts, the isoelectric point, electropho- 
retic migration, and heat stability of lymphoblast APRT were identical to 
normal in the five heterozygotes studied, with no evidence of an altered gene 
product as we also observed in hemolysate from these subjects. Resolution of 
this question will probably require an analysis of the levels of APRT mRNA 
in appropriate tissue from subjects who are heterozygous for APRT deficien- 
cy. 
In this study we have demonstrated a difference in APRT activity and 
CRM levels between erythrocytes and lymphoblasts derived from subjects 
heterozygous for APRT deficiency in one large family. Although we have 
suggested mechanisms to account for this difference, we were not able to 
distinguish between them at this time. Such a difference, however, leads us to 
suggest the desirability of lymphoblasts as the tissue of choice for further 
studies of the molecular mechanisms involved in APRT deficiency. Not only 
are lymphoblasts actively synthesizing new protein for studying the molecular 
and physical properties of APRT, but also they may serve as a source of DNA 
and RNA for studying the dynamic processes of normal and abnormal gene 
expression. In a similar fashion, lymphoblasts have been suggested as the 
tissue of choice in studying the mechanisms of other inborn errors of 
metabolism such as HPRT deficiency (Wilson et al., 1982). 
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